| DNA methylation regulates MicroRNA expression L Han, PDW Witmer, E Casey, D Valle, S Sukumar Cancer biology & therapy 6 (8), 1290-1294, 2007 | 431 | 2007 |
| Alterations in vascular gene expression in invasive breast carcinoma BS Parker, P Argani, BP Cook, H Liangfeng, SD Chartrand, M Zhang, ... Cancer research 64 (21), 7857-7866, 2004 | 275 | 2004 |
| Targeting glutamine metabolism in breast cancer with aminooxyacetate P Korangath, WW Teo, H Sadik, L Han, N Mori, CM Huijts, F Wildes, ... Clinical cancer research 21 (14), 3263-3273, 2015 | 165 | 2015 |
| Epigenetic Inactivation of the Potential Tumor Suppressor Gene FOXF1 in Breast Cancer PK Lo, JS Lee, X Liang, L Han, T Mori, MJ Fackler, H Sadik, P Argani, ... Cancer research 70 (14), 6047-6058, 2010 | 99 | 2010 |
| Combined treatment with epigenetic, differentiating, and chemotherapeutic agents cooperatively targets tumor-initiating cells in triple-negative breast cancer VF Merino, N Nguyen, K Jin, H Sadik, S Cho, P Korangath, L Han, ... Cancer research 76 (7), 2013-2024, 2016 | 47 | 2016 |
| The Notch pathway inhibits TGFβ signaling in breast cancer through HEYL-mediated crosstalk L Han, A Diehl, NK Nguyen, P Korangath, W Teo, S Cho, S Kominsky, ... Cancer Research 74 (22), 6509-6518, 2014 | 40 | 2014 |
| Effective treatment of ductal carcinoma in situ with a HER-2-targeted alpha-particle emitting radionuclide in a preclinical model of human breast cancer T Yoshida, K Jin, H Song, S Park, DL Huso, Z Zhang, H Liangfeng, C Zhu, ... Oncotarget 7 (22), 33306, 2016 | 32 | 2016 |
| ADP ribosylation by PARP-1 suppresses HOXB7 transcriptional activity X Wu, S Ellmann, E Rubin, M Gil, K Jin, L Han, H Chen, EM Kwon, J Guo, ... PloS one 7 (7), e40644, 2012 | 19 | 2012 |
| HEYL regulates neoangiogenesis through overexpression in both breast tumor epithelium and endothelium L Han, P Korangath, NK Nguyen, A Diehl, S Cho, WW Teo, L Cope, ... Frontiers in Oncology 10, 581459, 2021 | 11 | 2021 |
| A new perspective on Estrogen Receptor beta in breast cancer progression L Han Cancer biology & therapy 11 (7), 644-646, 2011 | 4 | 2011 |
| Regulation of angiogenesis in cancer and its therapeutic implications L Han, AM Lorincz, S Sukumar Antiangiogenic Agents in Cancer Therapy, 331-349, 2008 | 3 | 2008 |
| Abstract P2-09-01: Reactivation of epigenetically silenced retinoic acid receptor-beta for therapy of breast cancer-from molecular mechanism to potential clinical applications P Ordentlich, N Nguyen, K Jin, H Sadik, L Han, S Sukumar Cancer Research 72 (24_Supplement), P2-09-01-P2-09-01, 2012 | 2 | 2012 |
| HEYL, an overexpressed gene in breast cancer, functions as a novel negative regulator of TGF-β pathway L Han, JS LEE, T Mori, H Zhang, G Landberg, A Kallioniemi, P Argani, ... Cancer Research 68 (9_Supplement), 5201-5201, 2008 | 1 | 2008 |
| Heyl as a therapeutic target and a diagnostic marker for neoplasia and uses therefor S Sukumar, L Han | 1 | 2007 |
| Erratum: Alterations in vascular gene expression in invasive breast carcinoma (Cancer Research (November 1, 2004) 64, 1 (7857-7866)) BS Parker, P Argani, BP Cook, H Liangfeng, SD Chartrand, M Zhang, ... Cancer Research 64 (23), 8794, 2004 | 1 | 2004 |
| The Notch pathway inhibits TGF-β signaling in breast cancer through HEYL-mediated crosstalk. H Liangfeng, A Diehl, NK Nguyen, P Korangath, T Weiwen, Z Zhang, ... Cancer Research 73 (8_Supplement), 3123-3123, 2013 | | 2013 |
| Study the role of HEYL in breast tumorigenesis L Han, S Sukumar Cancer Research 71 (8_Supplement), 3876-3876, 2011 | | 2011 |
| HEYL, a Novel Negative Regulator of TGF-beta Pathway in Breast Cancer L Han Johns Hopkins University, 2008 | | 2008 |
| Characterization of the Role of Heyl in Angiogenesis and Breast Cancer Development L Han, JOHNS HOPKINS UNIV BALTIMORE MD | | 2005 |
